Popular on TelAve
- Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026 - 237
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed - 237
- WhereTu Launches to Help Americans Build Successful Lives Abroad - 205
- Dentists launch independent platform to help practices choose the right technology - 156
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake - 151
- Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence - 126
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Rare 1933 Harold Weston painting will be auctioned to benefit the Keene Valley Library
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
- Blue-Collar Working Mother Launches CommunLine to Bring Stable,Family-First Wireless Service to Ever
Similar on TelAve
- Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
- Postmortem Pathology Expands Access to Private Autopsy Services in Las Vegas
- Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
- AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
- FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
- Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
- Medical Experts Highlight the Importance of Second Opinions in Death Investigations
PurMa Biologics Publishes Free Mycoplasma Detection Protocol for Cell Culture Researchers
TelAve News/10899036
Oklahoma City biotech company releases step-by-step mycoplasma detection and elimination protocol
OKLAHOMA CITY - TelAve -- OKLAHOMA CITY, OK — PurMa Biologics, a leading manufacturer of cell culture reagents and biologics services, has published a comprehensive mycoplasma detection and elimination protocol available free to the scientific community via protocols.io.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on TelAve News
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on TelAve News
- Fatal FOMO May be Your Last Roll of the Dice
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Telecom Equipment Group Launches AI-Ready Modular Infrastructure Solution for Next-Gen Networks
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Source: PurMa Biologics
0 Comments
Latest on TelAve News
- NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
- Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers
- Where Is Your Faith The Movie and Sountrack
- Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
- Rev-O-Box™ Launches Reversible Shipping Box That Instantly Becomes a Premium Gift Box
- Las Vegas Estate Firm Ghandi Deeter Blackham Offers Insight on Tony Hsieh's Contested $500 Million Will
- CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
- Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
- Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
- Achugogo: Tale of the Spring Chaser Wins Inaugural TCCF Prize at Mifa Pitches, the Industry Market of the Annecy International Animation Film Festival
- Dear Sarah, an AI Companion App Made for Women, Launches Today
- Everything Policy Launches Madison, an AI Tool That Makes Legislation Readable for Students and Citizens
- Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
- Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
- Nevada Boxing Hall of Fame Gears Up for Star-Studded 14th Annual Induction Gala Weekend
- New Thriller 'Counterframe' Explores the Hidden Vulnerabilities of Modern Society
- Award-Winning Heritage at South Brunswick Continues to Thrive as One of New Jersey's Premier New Home Communities
- Four Seasons Cleaners Debuts Santa Barbara County's First 24/7 Dry Cleaning Kiosk New self-service
- WhereTu Launches to Help Americans Build Successful Lives Abroad
- Appliance EMT Expands Built-In and Walk-In Refrigerator Service in Metro Atlanta